Appropriate information provision about covid-19 and sars-cov-2 vaccine improves vaccination anxiety in patients with autoimmune liver disease.

ABSTRACT

The coronavirus disease 2019 (COVID-19) rapidly spread worldwide. Although several vaccines have been developed to control the spread of the disease, the safety and efficacy of the vaccine to patients with autoimmune liver disease are uncertain. However, subjects need to decide whether to receive the vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study found that 29 of 40 patients with autoimmune liver disease experienced anxiety to receive the SARS-CoV-2 vaccine. After providing information about COVID-19 and the vaccines, the number of patients with vaccination anxiety was reduced from 40 to 14 (p=0.000685). Appropriate provision of the information of COVID-19 and the vaccine improved vaccine anxiety in patients with autoimmune liver disease.Copyright © 2021 The Japan Society of Hepatology.